Thermo Fisher, NanoPin partner on infectious disease tech
Thermo Fisher Scientific will partner with infectious diseases diagnostic company NanoPin Technologies to develop workflows for liquid chromatography-mass spectrometry.
Bioprocessing Summit Europe to be held March 24-26
The Bioprocessing Summit Europe will return to Barcelona, Spain, this year to address the growing global market for gene therapy and biopharmaceutical manufacturing. The summit will take place from March 24 to 26.
Catalent completes acquisition of MaSTherCell
Catalent announced on February 11 that it has completed its acquisition of MaSTherCell Global, improving Catalent's position in the field of advanced biotherapeutics.
GenapSys launches sequencer in Asia, lands new funding
GenapSys has launched its gene sequencer in the Asia-Pacific region and garnered $75 million in financing to support its international expansion.
Arbor offers NGS coronavirus panel to researchers for free
Arbor Biosciences announced on February 12 that it will release its myBaits Expert hybridization-based panel for detecting infection with the 2019 novel coronavirus (2019-nCoV). The next-generation sequencing (NGS) panel will be offered free of charge to global researchers helping to identify the source organism and evolution of the virus.
WHO officially names coronavirus disease COVID-19
The World Health Organization (WHO) on February 11 announced an official designation for the disease caused by the novel coronavirus (2019-nCoV), naming the condition COVID-19.
Opposition fails for key CRISPR patent in Europe
ERS Genomics announced on February 10 that the European Patent Office has upheld an important CRISPR patent, rejecting opposition filed by anonymous parties.
Bosc named president of Women in Bio
Jessica Bosc, director of business development and licensing at Selexis, has been named president of Women in Bio, following a one-year term as president-elect.
ERS Genomics licenses CRISPR tech to Aelian
ERS Genomics announced on February 11 that it has entered an agreement to license its portfolio of CRISPR technology to Aelian Biotechnology.
MilliporeSigma unveils BrightLab for research scientists
MilliporeSigma has introduced BrightLab, a cloud-based inventory management and instrument connectivity platform for research scientists.